1 | | FMOC-GLU-ODMAB | FMOC-GLU-ODMAB | C40H44N2O8
| | |
2 | 172611-75-5 | N-[(9H-芴-9-基甲氧基)羰基]-L-谷氨酸 1-[[4-[[1-(4,4-二甲基-2,6-二氧代环己亚基)-3-甲基丁基]氨基]苯基]甲基]酯 | FMOC-GLU(ODMAB)-OH | C40H44N2O8
| 氨基酸衍生化合物;Fmoc-保护氨基酸 | |
3 | 607732-61-6 | 纳曲酮杂质 | Naltrexone Impurity | C40H44N2O8
| 药品杂质;杂质对照品;原料药杂质 | |
4 | | 1,1'-Bis(pivaloyloxy)-6,6',7,7'-tetrahydroxy-5,5'-diisopropyl-3,3'-dimethyl-2,2'-binaphthalene-8,8'-dicarbonitrile | 1,1'-Bis(pivaloyloxy)-6,6',7,7'-tetrahydroxy-5,5'-diisopropyl-3,3'-dimethyl-2,2'-binaphthalene-8,8'-dicarbonitrile | C40H44N2O8
| | |
5 | | 1,1'-Bis(pentanoyloxy)-6,6',7,7'-tetrahydroxy-5,5'-diisopropyl-3,3'-dimethyl-2,2'-binaphthalene-8,8'-dicarbonitrile | 1,1'-Bis(pentanoyloxy)-6,6',7,7'-tetrahydroxy-5,5'-diisopropyl-3,3'-dimethyl-2,2'-binaphthalene-8,8'-dicarbonitrile | C40H44N2O8
| | |
6 | 874486-65-4 | (4R)-5-[(4-{[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl]amino}phenyl)methoxy]-4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-5-oxopentanoic acid | (4R)-5-[(4-{[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl]amino}phenyl)methoxy]-4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-5-oxopentanoic acid | C40H44N2O8
| | |
7 | 53416-82-3 | 5,6,11,12-Tetrahydro-3,8,9-trimethoxy-13-methyl-1-[[(6aS)-5,6,6a,7-tetrahydro-1,2,10-trimethoxy-6-methyl-4H-dibenzo[de,g]quinolin-9-yl]oxy]-5α,11α-epiminodibenzo[a,e]cycloocten-4-ol | 5,6,11,12-Tetrahydro-3,8,9-trimethoxy-13-methyl-1-[[(6aS)-5,6,6a,7-tetrahydro-1,2,10-trimethoxy-6-methyl-4H-dibenzo[de,g]quinolin-9-yl]oxy]-5α,11α-epiminodibenzo[a,e]cycloocten-4-ol | C40H44N2O8
| | |